
Switzerland Remains Eighth In International Patent Applications
- Français fr La Suisse toujours huitième des demandes internationales de brevet Original Read more: La Suisse toujours huitième des demandes internationales de breve
- 日本語 ja 世界の特許出願、中国が首位 日本3位、スイス8位 Read more: 世界の特許出願、中国が首位 日本3位、スイス8
+ Get the most important news from Switzerland in your inbox
In total, more than 273,000 applications were received, the Geneva-based institution said on Monday. Last year, digital messages led patent applications, accounting for 10.5% of the total.
Behind Beijing, with more than 70,000, comes the United States and Japan. Of the major countries, only China and South Korea recorded growth last year.
The US recorded a fall in applications for the third year running. Switzerland also saw a decline, from almost 5,400 to just over 5,300.
No Swiss company is among the top 50 in terms of innovation, adds WIPO. However, the Ecole polytechnique fédérale de Lausanne (EPFL) is ranked 41st among academic institutions.
Better for NovartisOn the trademark front, the total number of applications is estimated to have risen again, by 1.2%, after two consecutive years of decline. With more than 11,000 applications, the US is ahead of Germany and China.
Switzerland, which remains in 6th place, saw an increase. With 193 applications, Novartis moved up two places to second place among companies.
For industrial designs, a record of more than 27,000 applications was reached, an increase for the fourth year running, this time of almost 7%. China is ahead of Germany and the US, while Switzerland has dropped one place to fifth, with a decline in the number of applications.
Four Swiss companies appear between 37th and 50th place on the list, according to WIPO.
Translated from French with DeepL/mga

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment